Active	Status	Sponsor type	Region	Phase	Filter
1 Active 6 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Alecsat (cytotoxic lymphocyte-based cancer vaccine) / CytoVac
NCT04609215: ImmunoBreast - A Phase Ib Study	Recruiting	1/2	20	Europe	ALECSAT, Adoptive cell therapy	Henrik Ditzel, CytoVac A/S, National Board of Health, Denmark	Triple Negative Breast Cancer, Breast Cancer, Metastatic Breast Cancer	05/23	05/23